Follistatin 315
Research Goal: Assessing the inhibition of TGF-β ligands, specifically myostatin and activin A, for muscle growth acceleration.
Route
Subcutaneous injection
Dose range
100 mcg
Frequency
Often used in short "pulses" (10–30 days)
Cycle length
10–30 days, followed by a significant washout period (4–8 weeks)
Overview
Research Goal: Assessing the inhibition of TGF-β ligands, specifically myostatin and activin A, for muscle growth acceleration.
Preparation: Reconstitute with 1.0 mL sterile water. Handle with extreme care; avoid vigorous shaking.
Studied benefits
- A potent myostatin inhibitor that promotes muscle growth by blocking the proteins that limit muscle tissue development
- It is studied for its ability to increase lean muscle mass and improve strength, particularly in conditions involving muscle wasting
Reported side effects
- Research is primarily preclinical
- potential side effects may include temporary joint or muscle soreness and a potential impact on tendon strength due to rapid muscle growth
Protocol
Dosing Schedule (Subcutaneous/Intramuscular)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Protocol | Dose (mcg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Loading Pulse | 100 mcg | 4 units (0.04 mL) | + Log |
| Standard Cycle | 100 mcg | 4 units (0.04 mL) | + Log |
Frequency
Often used in short "pulses" (10–30 days).
Timing
Any time; post-workout is common in muscle research models.
Cycle length
10–30 days, followed by a significant washout period (4–8 weeks).
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
50 doses of 100 mcg per vial
At the starting dose (100 mcg × 7/week for a 4-week cycle) you would use about 2.8 mg, i.e. 1 × 5 mg vial. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a high-protein, hypercaloric diet to provide the massive amount of energy and substrate required for the significant muscle hypertrophy associated with myostatin inhibition. Follow a high-intensity resistance training program to provide the mechanical stimulus necessary to guide the increased muscle-building potential toward functional growth. Ensure 7–9 hours of quality sleep for deep muscular recovery and to manage systemic inflammation. Monitor joint and tendon health closely, as muscle strength may increase more rapidly than the connective tissue's ability to adapt, necessitating a cautious and progressive approach.
Evidence
Research summaries
Follistatin Gene Delivery Enhances Muscle Growth and Strength
Findings: significant increases in muscle mass, creates "super-muscles" by blocking growth limits, circulating form reaches whole body.
Your body has a natural brake pedal for muscle growth called "myostatin," which stops you from getting too bulky. Follistatin 315 is the protein that cuts that brake line. Unlike other versions that get stuck to the walls of your cells, Follistatin 315 floats freely in the blood (circulation), meaning it can travel to muscles all over the body. In this study, animals treated with Follistatin 315 saw their muscles grow massive—up to 40-60% larger—without any exercise. Crucially, the muscle wasn't just "puffy"; it was strong and functional. The 315 version is special because it has a "tail" that hides it from sticky cell surfaces, allowing it to stay in the blood longer to do its job. It’s the ultimate muscle-building signal.
Read the study ↗Bone Geometry Is Altered by Follistatin-Induced Muscle Growth
Findings: Strengthens bones to support new muscle, changes bone shape to handle more weight, prevents injury.
If you put a Ferrari engine in a bicycle, the frame would break. Similarly, if muscles get too strong too fast, they could snap the bone. This research checked if Follistatin 315 caused that problem. Good news: it didn't. When the peptide caused muscle hypertrophy (growth), the bones naturally adapted by changing shape and getting stronger at the attachment points (like the tibia). This proves that the body works as a system; the signal from Follistatin 315 doesn't just make you swole, it triggers a "whole body" upgrade so your skeleton can handle the new power. This is important for treating muscle-wasting diseases where bones often become brittle.
Read the study ↗Follistatin-Based Molecule Increases Muscle Regeneration After Injury
Findings: Speeds up healing of torn muscles, reduces inflammation, and restores strength faster than natural recovery.
Recovering from a torn muscle usually takes weeks. Researchers tested a version of Follistatin 315 on injured muscles and found it acted like a super-healer. It controlled the early inflammation (swelling) and helped the muscle stem cells (satellite cells) multiply faster. The treated muscles repaired themselves with less scarring and more healthy fiber. This suggests that Follistatin 315 isn't just for building bodybuilder size, but could be a game-changer for athletes recovering from surgery or tears, getting them back on the field in record time.
Read the study ↗More references (5)
- Follistatin Promotes Myocyte Proliferation in Pigs with Postinfarction LV Remodeling, 2025
- Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates, 2010
- Role of Follistatin in Promoting Adipogenesis in Women, 2011
- Regulation of Follistatin Splicing and Muscle Mass, 2009
- Follistatin Expression in Human Skeletal Muscle, 2007
Identification
Chemistry
- cas
- 214047-00-4 (for palmitoylated derivative); 10068-24-7 (for native follistatin); not universally standardized across all suppliers
- formula
- C₁₅₈H₂₅₁N₄₇O₆₀S₁ (estimated for glycosylated native protein); variations exist depending on glycosylation state and salt form
- molecular weight
- ~35 kDa for recombinant protein; 32,000-35,000 Da for native protein depending on glycosylation degree
- sequence
- Mature sequence: Gly30 to Trp344 (314 amino acids); N-terminal domain (residues 30-92), three follistatin modules (FS modules 1-3), C-terminal extension (acidic tail unique to FS315)
- source
- Natural; products from alternative splicing of the FST gene (UniProt P19883)
- biosynthesis
- Ribosomal; translated from mRNA generated by alternative splicing of transcripts from a single FST gene locus
- type
- Monomeric glycoprotein; contains 36 cysteine residues forming multiple disulfide bonds creating structural domains characteristic of mosaic proteins
Keep exploring
Related peptides
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
AICAR
Acadesine · AICA-Riboside
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
BPC-157, TB-500
- Route
- Subcutaneous
- Dose
- 333 mcg – 667 mcg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC)
No DAC
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks